Sunshine Biopharma (SBFM) Stock Price
Sunshine Biopharma Price
Revenue has compounded at 170.9% per year over the past 10 years to 36.31 M USD. Sunshine Biopharma's net margin stands at -16.5%, up from -5,444.4% several years earlier. Analysts set a median price target of 6.12 USD, implying 116.3% above the current price. Of 7 analysts, 6 rate the stock a buy — an overall Buy consensus.
Sunshine Biopharma stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Sunshine Biopharma business model & stock analysis
Frequently asked questions about Sunshine Biopharma
Analysts currently set an average price target of 6.12 USD for the Sunshine Biopharma stock (median: 6.12 USD), implying +116.3 % versus the latest price. The consensus is based on 7 analyst ratings.
7 analysts currently rate the Sunshine Biopharma stock: 6 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Sunshine Biopharma to generate revenue of 36.75 M USD and earnings per share of -2.79 USD.
Converted at the current exchange rate, the Sunshine Biopharma share trades at 2.53 EUR (2.83 USD).
The Sunshine Biopharma share (SBFM) is listed on 1 stock exchanges, including: NASDAQ (SBFM).
The expected revenue of Sunshine Biopharma is 36.75 M USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Sunshine Biopharma is -1.37 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Sunshine Biopharma is currently -1.01. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Sunshine Biopharma stock.
The price-to-sales ratio (P/S) of Sunshine Biopharma is currently 0.04. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Sunshine Biopharma stock.
The Eulerpool Quality Score for Sunshine Biopharma is 5/10.
The ISIN of Sunshine Biopharma is US8677817004. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Sunshine Biopharma is SBFM. The ticker symbol is used to trade Sunshine Biopharma shares on the stock exchange.
Sunshine Biopharma stock
Sunshine Biopharma Peer Group
Sunshine Biopharma Ticker
All fundamentals and in-depth analysis of Sunshine Biopharma
Our stock analysis for Sunshine Biopharma stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sunshine Biopharma. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.